Health & Pharma Headlines:
- Vibrating Capsule Shows Promise for Chronic Constipation: New research presented at Digestive Disease Week (DDW) 2025 indicates that a vibrating capsule can significantly increase the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation. The capsule creates distinct peaks of activity in the morning and evening.
- FDA Accepts BioCryst's Application for Hereditary Angioedema Drug in Children: The U.S. Food and Drug Administration has accepted BioCryst's New Drug Application (NDA) and granted priority review for berotralstat oral granules for children aged 2 to 11 with hereditary angioedema (HAE). If approved, it would be the first oral prophylactic therapy for HAE in this age group.
- Akums Advances Tablet-in-Capsule Technology: Contract Development and Manufacturing Organization (CDMO) Akums Drugs and Pharmaceuticals highlights its expertise in tablet-in-capsule technology, which allows for combining multiple drugs with different release profiles in a single dosage form, potentially improving patient adherence.
- MIT Develops Bio-Inspired Drug Capsule: Researchers at MIT and Novo Nordisk have created an ingestible capsule inspired by squids that can inject drugs directly into the wall of the gastrointestinal tract. This needle-free approach could be used for delivering biologics like insulin and RNA-based therapies.
Other Capsule-Related News:
- SpaceX Heavily Favored in Trump's NASA Budget Proposal: U.S. President Donald Trump's 2026 budget plan reportedly allocates significant funding towards SpaceX for defense and space initiatives.
- Return of Chinese Astronauts Delayed Due to Weather: The return of three Chinese astronauts from the Shenzhou-19 mission to the Tiangong space station was postponed due to unfavorable weather conditions in Inner Mongolia but they have since returned safely.
- Natural Capsules Ltd. Announces Company Secretary Resignation: Natural Capsules Ltd. has announced the resignation of its Company Secretary and Compliance Officer, effective May 7, 2025.
